Interestingly, comparison of hormone-sensitive prostate cancer cell models to their CRPC-derivative models often demonstrated higher basal G6PD levels in the CRPC models, perhaps reflecting the high basal levels of AR activity in these cells (Supplementary Figure 3B). The gene discussed is AR; the disease is prostate cancer.